Analysis identifies a specific methylation profile in BAP1-deficient meningiomas, suggesting aggressive behavior.
Summary Undifferentiated cytokeratin‐expressing non rhabdoid meningeal tumor can correspond to BAP1 ‐deficient meningiomas. DNA methylation profiling identifies a methylation class specific to BAP1 ‐deficient meningioma. BAP1 ‐deficient meningiomas are aggressive relapsing tumours.
No takes yet. Share an insight, caveat, or question.
Drabent et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: